CIK 0001684144 · Non-accelerated filer<br>Smaller reporting company
Zomedica Corp.
Sign in to watch- Ticker
- ZOMDF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Alberta, Canada
- Entity type
- operating
- Phone
- (734) 369-2555
- Business address
- 1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
- Former names
- Zomedica Pharmaceuticals Corp.
- 4 Open-market buy COO bought 100,000 shares at $0.14 ($14,200)
- 4 Open-market buy Vice President of Sales bought 299,993 shares at $0.16 ($46,529)
- 4 Open-market buy Vice President of Sales bought 700,007 shares at an average $0.15 ($105,041)
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.15 ($3,798)
- 4 Open-market buy Director bought 100,000 shares at an average $0.17 ($17,450)
- 4 Open-market buy Director bought 25,000 shares at $0.18 ($4,600)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 50,000 shares at an average $0.14 ($6,981)
- 4 Open-market buy Director bought 100,000 shares at $0.14 ($14,000)
- 4 Open-market buy COO bought 150,000 shares at $0.14 ($21,000)
- 4 Open-market buy CEO bought 100,000 shares at $0.14 ($14,200)
- 4/A Open-market buy Director bought 100,000 shares at $0.17 ($16,500)
- 4 Open-market buy Director bought 100,000 shares at $0.17 ($16,500)
- 4 Open-market buy Director bought 100,000 shares at $0.17 ($16,600)
- 4 Open-market buy CEO bought 100,000 shares at $0.17 ($16,600)
- 4 Open-market buy Director bought 150,000 shares at $0.17 ($25,950)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO bought 100,000 shares at $0.19 ($19,090)
Page 4 of 10 · 183 filings